PharmChem (PharmChem) EV-to-EBITDA : 39.12 (As of May. 14, 2024)

PharmChem EV-to-EBITDA Chart

PharmChem Annual Data
	Trend	Dec93	Dec94	Dec95	Dec96	Dec97	Dec98	Dec99	Dec00	Dec01	Dec02
EV-to-EBITDA		Get a 7-Day Free Trial					9.21	4.46	7.40	-2.57	2.50

PharmChem Quarterly Data
	Jun99	Sep99	Dec99	Mar00	Jun00	Sep00	Dec00	Mar01	Jun01	Sep01	Dec01	Mar02	Jun02	Sep02	Dec02	Mar03	Jun03	Sep03	Sep22	Sep23
EV-to-EBITDA	Get a 7-Day Free Trial															4.42	6.40	7.35	49.32	36.33

Competitive Comparison of PharmChem's EV-to-EBITDA

For the Diagnostics & Research subindustry, PharmChem's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PharmChem's EV-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, PharmChem's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where PharmChem's EV-to-EBITDA falls into.

PharmChem EV-to-EBITDA Calculation

PharmChem's EV-to-EBITDA for today is calculated as:

PharmChem's current Enterprise Value is $11.85 Mil.
PharmChem's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmChem  (OTCPK:PCHM) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

PharmChem's PE Ratio for today is calculated as:

PharmChem's share price for today is $2.60.
PharmChem's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.044.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

PharmChem EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of PharmChem's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmChem (PharmChem) Business Description